Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.3218
$0.02357.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.73M | 12.29M | 13.31M | 13.32M | 13.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.64M | 53.97M | 58.43M | 58.71M | 55.85M |
| Operating Income | -53.64M | -53.97M | -58.43M | -58.71M | -55.85M |
| Income Before Tax | -33.30M | -33.97M | -34.27M | -31.08M | -28.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.30 | -33.97 | -34.27 | -31.08 | -28.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.30M | -33.97M | -34.27M | -31.08M | -28.77M |
| EBIT | -53.64M | -53.97M | -58.43M | -58.71M | -55.85M |
| EBITDA | -53.53M | -53.86M | -58.33M | -58.61M | -55.75M |
| EPS Basic | -0.73 | -0.87 | -0.96 | -0.93 | -0.92 |
| Normalized Basic EPS | -0.46 | -0.55 | -0.60 | -0.58 | -0.57 |
| EPS Diluted | -0.75 | -0.88 | -0.97 | -0.94 | -0.92 |
| Normalized Diluted EPS | -0.46 | -0.55 | -0.60 | -0.58 | -0.57 |
| Average Basic Shares Outstanding | 186.99M | 158.90M | 145.24M | 135.19M | 124.74M |
| Average Diluted Shares Outstanding | 186.99M | 158.90M | 145.24M | 135.19M | 124.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |